BioCentury
ARTICLE | Company News

Intronn, Virxsys deal

October 1, 2007 7:00 AM UTC

Virxsys acquired all the core technology and preclinical programs of Intronn for an undisclosed amount of stock. Intronn's spliceosome-mediated RNA trans-splicing (SMaRT) technology inserts a new sequ...